Inhibikase Therapeutics, Inc. - IKT

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$296.9M
QoQ value delta ($000)
+$105.5M (+55.09%)
Implied price effect (QoQ)
+49.97%
Shares
Total shares
117,883,064
QoQ shares delta
+3,888,113 (+3.41%)
Total shares held by funds (by quarter)

Market chart (IKT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 105 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
CAXTON CORP 57,759 28,453 3.12%
Sands Capital Alternatives, LLC 26,428 13,018,965 4.31%
Soleus Capital Management, L.P. 22,076 10,875,000 0.76%
Trails Edge Capital Partners, LP 18,374 9,051,318 2.92%
Fairmount Funds Management LLC 17,508 8,625,000 1.16%
BlackRock, Inc. 15,769 7,768,057 0.0%
ADAR1 Capital Management, LLC 14,996 7,387,205 0.69%
Blackstone Inc. 12,054 5,938,276 0.04%
Siren, L.L.C. 11,875 5,850,000 0.24%
Commodore Capital LP 10,956 5,397,488 0.65%
VANGUARD CAPITAL MANAGEMENT LLC 10,018 4,935,354 0.0%
MILLENNIUM MANAGEMENT LLC 8,177 4,028,102 0.0%
Saturn V Capital Management LP 7,854 3,869,056 1.13%
Kalehua Capital Management LLC 7,758 3,821,890 5.56%
Spruce Street Capital LP 7,270 3,581,603 1.43%
Squadron Capital Management LLC 6,090 3,000,000 1.89%
Nantahala Capital Management, LLC 5,484 2,701,863 0.18%
GEODE CAPITAL MANAGEMENT, LLC 5,293 2,607,129 0.0%
STATE STREET CORP 3,875 1,909,101 0.0%
SummitTX Capital, L.P. 3,613 1,780,262 0.09%
Integral Health Asset Management, LLC 2,740 1,350,000 0.11%
NORTHERN TRUST CORP 1,783 878,585 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 1,643 809,490 0.0%
TWO SIGMA INVESTMENTS, LP 1,636 806,264 0.0%
SPHERA FUNDS MANAGEMENT LTD. 1,318 649,309 0.17%